LIQUID BIOPSY, ctDNA, EGFR

Patients positive for EGFR mutations benefit from Tyrosine kinase inhibitors. This test uses Whole blood as the specimen (Liquid Biopsy) to detect mutations in Exon 19 (E746_A750del), Exon 20 (T790M) and Exon 21 (L858R). T790M mutation is a resistance mutation which benefits from third generation TKI's like Osimertinib.

  • Test Type:
  • Pre-test Information:
  • Report Delivery:
    Sample Mon / Thu 9 am; Report Fri / Tue
  • Components:
    0